Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

immunology and microbiology

Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis

Tuberculosis, Volume 99, Year 2016

Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summarize data on PZA resistance in clinical isolates from South Africa. PZA DST should be performed when considering its inclusion in treatment of patients with rifampicin-resistant TB or MDR-TB.

Whitfield, Michael G.
1. South Africa, Stellenbosch Stellenbosch University
Streicher, Elizabeth Maria
1. South Africa, Stellenbosch Stellenbosch University
Dolby, Tania
1. South Africa, Johannesburg National Health Laboratory Service
Simpson, John A.
1. South Africa, Johannesburg National Health Laboratory Service
Sampson, Samantha Leigh
1. South Africa, Stellenbosch Stellenbosch University
Van Helden, Paul D.
1. South Africa, Stellenbosch Stellenbosch University
van Rie, Annelies
1. United States, Chapel Hill The University of North Carolina at Chapel Hill
2. Belgium, Wilrijk Faculteit Geneeskunde en Gezondheidswetenschappen
Warren, Robin Mark
1. South Africa, Stellenbosch Stellenbosch University

AFRICAN RESEARCH NEXUS

Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis

Disclaimer

African Research Nexus

Useful Links

AFRICAN RESEARCH NEXUS

Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis

Description

Authors & Co-Authors

Disclaimer

African Research Nexus

Useful Links